drugset / Trial / NCT01564199
Phase I Pharmacokinetic Study (SALBLOCK)
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of the study is to assess the extent to which the charcoal prevents the absorption of salmeterol and fluticasone via the GI tract. The assessment will be based on comparing the pharmacokinetic parameter area under the concentration-time curve (AUCt).
Timeline
- Start
- 2012-04
- Primary completion
- 2012-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 1000 ug | Oral |
| Subject | Salmeterol | Other / unclassified | 100 ug | Oral |
Indications
No indication recorded.